|
|
||||||||
The Annals of Thoracic Surgery, Vol 47, 400-406, Copyright © 1989 by The Society of Thoracic Surgeons
LD Griffith, GF Billman, PO Daily and TA Lane
We found that reinfusion of shed mediastinal blood (SMB) after a cardiac
operation was associated with laboratory evidence of disseminated
intravascular coagulation. In view of this, we compared the effect of
infusing washed or unwashed SMB on the coagulation profiles and blood use
of two serial groups of patients undergoing cardiopulmonary bypass. We
found that the results of testing for fibrin degradation products converted
from negative to positive in 17 of 20 patients who received unwashed SMB
versus 1 of 14 patients who received washed SMB (p less than 0.0001). Other
coagulation studies did not reveal disseminated intravascular coagulation
in either group, nor were there differences in blood use between the two
groups. The unwashed SMB contained high titers of fibrin degradation
products (mean reciprocal titer = 354 +/- 161) compared with washed SMB
(mean reciprocal titer = 34 +/- 18) (p less than 0.01). Based on the volume
of SMB infused, the amount of fibrin degradation products in unwashed SMB
was sufficient to account for the positive fibrin degradation product
assays after infusion in this group. We conclude that infusion of unwashed
SMB may confuse the interpretation of tests for disseminated intravascular
coagulation or fibrinolysis. As this could lead to unnecessary blood
component use and is preventable by washing before infusion, we recommend
that the routine infusion of unwashed SMB no longer be employed.
ARTICLES
Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate
Department of Cardiothoracic Surgery, University of California, San Diego.
This article has been cited by other articles:
![]() |
R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text] |
||||
![]() |
T Amand, J Pincemail, F Blaffart, R Larbuisson, R Limet, and J O Defraigne Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit Perfusion, March 1, 2002; 17(2): 117 - 123. [Abstract] [PDF] |
||||
![]() |
A. Belboul and N. Al-Khaja Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery Perfusion, December 1, 1997; 12(6): 385 - 391. [Abstract] [PDF] |
||||
![]() |
J. S. McKIE and J. E. HERZENBERG Coagulopathy Complicating Intraoperative Blood Salvage in a Patient Who Had Idiopathic Scoliosis. A Case Report J. Bone Joint Surg. Am., September 1, 1997; 79(9): 1391 - 4. [Full Text] |
||||
![]() |
R. A. Vertrees, V. R. Conti, S. D. Lick, J. B. Zwischenberger, L. B. McDaniel, and G. Shulman Adverse Effects of Postoperative Infusion of Shed Mediastinal Blood Ann. Thorac. Surg., September 1, 1996; 62(3): 717 - 723. [Abstract] [Full Text] |
||||
![]() |
J. P. Schonberger, P. A. Everts, J. J Bredee, E. Jansen, R. Goedkoop, J. H Bavinck, E. Berreklouw, and C. R. Wildevuur The effect of postoperative normovolaemic anaemia and autotransfusion on blood saving after internal mammary artery bypass surgery Perfusion, October 1, 1992; 7(4): 257 - 262. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |